Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial
Top Cited Papers
- 1 October 2004
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 364 (9444), 1505-1512
- https://doi.org/10.1016/s0140-6736(04)17273-5
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Asthma exacerbations during long term beta agonist use: influence of beta 2 adrenoceptor polymorphismThorax, 2000
- Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing.Journal of Clinical Investigation, 1997
- Comparison of Regularly Scheduled with As-Needed Use of Albuterol in Mild AsthmaNew England Journal of Medicine, 1996
- Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells.American Journal of Respiratory Cell and Molecular Biology, 1995
- Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthmaJournal of Allergy and Clinical Immunology, 1994
- Amino-Terminal Polymorphisms of the Human .beta.2-Adrenergic Receptor Impart Distinct Agonist-Promoted Regulatory PropertiesBiochemistry, 1994
- Regular inhaled beta agonist in asthma: effects on exacerbations and lung function.Thorax, 1993
- A Comparison of Salmeterol with Albuterol in the Treatment of Mild-to-Moderate AsthmaNew England Journal of Medicine, 1992
- Comparison of a β2-Agonist, Terbutaline, with an Inhaled Corticosteroid, Budesonide, in Newly Detected AsthmaNew England Journal of Medicine, 1991
- Regular inhaled beta-agonist treatment in bronchial asthmaThe Lancet, 1990